Clinical Trial Update: SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study SPD489 as adjunctive treatment for negative symptoms of schizophrenia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Negative Symptoms of Schizophrenia
• Schizophrenia

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: Negative Symptoms of Schizophrenia | Phase 3 | Status: WITHDRAWN